Polomar Health Services, Inc.
For the period ended Jul 9, 2025. Filed Jul 9, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jul 9, 2025 · Filed Jul 9, 2025
Contents
Cautionary Statement Regarding Forward-Looking Statements
This report may contain “forward-looking statements” within the meaning of the federal securities laws. All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties, and other factors, which may cause the actual results or performance of each company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks described under the headings “Risk Factors” and “Cautionary Statement Concerning Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and such other periodic filings the Company makes from time to time with the Securities and Exchange Commission.
You are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements are not guarantees of future performance, and actual results, developments, and business decisions may differ from those envisaged by our forward-looking statements. Except as required by law, we undertake no obligation to update such statements to reflect events or circumstances arising after the date of this press release, and we caution investors not to place undue reliance on any such forward-looking statements.
Item 9.01 Financial Statements and Exhibits.
| Exhibit | Description |
| 4.1 | Certificate of Designations of Series A Convertible Preferred Stock |
| 10.1 | Second Amendment to the Polomar Specialty Pharmacy, LLC-Reprise Promissory Note and Loan Agreement dated August 13, 2024. |
| 10.2 | Securities Purchase Agreement between Polomar Health Services, Inc., and Reprise Management, Inc. dated July 2, 2025 |
| 10.3 | First Amendment to Polomar Specialty Pharmacy, LLC-Reprise Promissory Note and Loan Agreement dated August 13, 202. |
| 10.4 | Securities Purchase Agreement between Polomar Health Services, Inc., and CWR 1, LLC dated July 2, 2025 |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.